Alphabet’s AI drug discovery startup Isomorphic Labs is reportedly close to raising more than $2 billion in new funding led by Thrive Capital. The fresh cash is set to expand its AI drug design engine and support global growth, reinforcing Alphabet’s push to commercialize advanced AI technology beyond research labs.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
